Pain relieving ointment recalled for packaging that is not child-resistant
About 50,330 jars of Mamisan Pain Relieving Topical Ointment are being recalled because the ointment contains lidocaine and the packaging is not child-resistant.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Scored 3 under the risk-of-harm criterion: packaging that is not child-resistant poses a poisoning risk to young children, with no incidents reported.
Plain-English summary
Mamisan Pain Relieving Topical Ointment jars are being recalled. The ointment comes in an orange 3.52 ounce plastic jar with a white continuous thread lid, with the Mamisan trademark printed on the lid and label, and a wraparound label carrying instructions and drug facts. Only jars with UPC code 860006498115 are included.
The ointment contains lidocaine, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children. No incidents have been reported.
About 50,330 units were sold at Walmart and Target stores nationwide and online at Target.com from April 2024 through October 2025 for about $10.
Consumers should immediately secure the recalled jars out of the sight and reach of children and contact Plantimex for a free replacement lid. Once the product is secured with the replacement lid, it can be used as directed.
The recalled product
- Product
- Mamisan Pain Relieving Topical Ointment
- Manufacturer
- MiramarLab, of Doral, Florida
- Category
- Drug — Topical analgesic
- Hazard
- poisoning
- child-resistant-packaging
- lidocaine
- child-safety
- Affected units
- 50,330
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
UPCs (1)
- 860006498115
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22